Rexis Biotech Inc. — Form C (Regulation Crowdfunding)
Rexis Biotech Inc. of Las Vegas, NV filed a Form C (Regulation Crowdfunding) with the SEC on 2023-12-08. Target raise $50K, up to $1.2M. Offered through Wefunder Portal LLC.
Offering
- Filed: 2023-12-08
- Form: C
- Accession: 0001670254-23-001115
- Target amount: $50K
- Maximum amount: $1.2M
- Security type: Preferred Stock
- Securities offered: 44,248
- Price: $1.2500
- Deadline: 2024-04-29
- Funding portal / intermediary: Wefunder Portal LLC
- Intermediary file number: 007-00033
- Intermediary CRD: 283503
Issuer
- CIK: 0002000970
- Website: https://www.rexissystems.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2022-01-24
- Address: 4364 E. Craig Rd, Las Vegas, NV, 89115
- Employees: 7
Financials (as filed)
- Total assets (most recent): $19
- Cash (most recent): $19
- Revenue (most recent): $191K
- Net income (most recent): $-76
People (3)
| Name | Role | Location |
|---|
| Keith Bushfield | CEO | Pompano Beach, FL |
| Daniel R Wittmers | Executive Vice President | Pompano Beach, FL |
| Simon Selkrig | CFO | Pompano Beach, FL |
Reg CF filing history (2)
More